Unique ID issued by UMIN | UMIN000047111 |
---|---|
Receipt number | R000053719 |
Scientific Title | Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease |
Date of disclosure of the study information | 2022/03/07 |
Last modified on | 2025/04/21 07:40:18 |
Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease
Effect of nerve block on Parkinson's disease
Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease
Effect of nerve block on Parkinson's disease
Japan |
Parkinson's disease
Neurology |
Others
NO
For patients with Parkinson's disease who complain of chronic abdominal pain and low back pain, block injection and trigger point injection to the anterior cutaneous nerve will be performed to evaluate the effect on pain and the effect on Parkinson's symptoms including posture abnormalities.
Efficacy
Confirmatory
Pain Questionnaire including visual analogue scale
(2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)
Unified Parkinson Disease Rating Scale, functional evaluation in rehabilitation, evaluation of waist bending angle
(2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)
Observational
20 | years-old | <= |
85 | years-old | > |
Male and Female
1) Patients diagnosed with Parkinson's disease by the British Brain Bank Clinical Criteria
2) H & Y classification II degree or higher
3) Patients aged between 20 and 85 at the time of consent
4) Gender does not matter
5) Patients who have voluntarily consented to the document
1) Patients with serious physical symptoms other than Parkinson's disease (cardiac / hepatic / renal dysfunction, hematopoietic disorders, etc.)
2) Viral hepatitis: HBsAg positive or HCV antibody positive
3) Women who are pregnant or may become pregnant
4) Patients with a history of hypersensitivity to the study drug
5) Patients with drug addiction / alcohol dependence
6) Patients with serious psychiatric symptoms (confusion, hallucinations, delusions, abnormal behavior, etc.) within 3 months before obtaining the consent form
7) Other patients who the doctor in charge deems inappropriate to participate in the study
20
1st name | Takuyuki |
Middle name | |
Last name | Endo |
Osaka Toneyama Medical Center
Neurology
565-0873
5-1-1, Toneyama, Toyonaka, Osaka
+81-6-6853-2001
endo.takuyuki.gr@mail.hosp.go.jp
1st name | Takuyuki |
Middle name | |
Last name | Endo |
Osaka Toneyama Medical Center
Neurology
565-0873
5-1-1, Toneyama, Toyonaka, Osaka
+81-6-6853-2001
endo.takuyuki.gr@mail.hosp.go.jp
Osaka Toneyama Medical Center
Japan Society for the Promotion of
Science
Other
Osaka Toneyama Medical Center Clinical Research Review Committee
5-1-1, Toneyama, Toyonaka, Osaka
06-6853-2001
410-chiken@mail.hosp.go.jp
NO
2022 | Year | 03 | Month | 07 | Day |
Unpublished
10
No longer recruiting
2018 | Year | 05 | Month | 18 | Day |
2018 | Year | 05 | Month | 18 | Day |
2018 | Year | 05 | Month | 18 | Day |
2026 | Year | 03 | Month | 31 | Day |
2026 | Year | 03 | Month | 31 | Day |
Observation period, 24 weeks
Inspection items
Background of research subjects
Diagnostic imaging
Chest X-ray, thoracolumbar MRI
Clinical examination
Hematological tests
electrocardiogram
Questionnaire for anesthesiology pain clinic
Evaluation of neurological symptoms
Evaluation in the rehabilitation department, 10m walking, 3m Time-up-go test
Pain Visual Analogue Scale, photos for posture evaluation
2022 | Year | 03 | Month | 07 | Day |
2025 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053719